Maximus, Inc. stock is expected to maintain momentum with strong financials and recent acquisitions.

From Nasdaq: 2025-01-07 13:26:00

Maximus, Inc. (MMS) shares have gained 8% in the past month and are expected to maintain momentum. With a Zacks Rank #2 and VGM Score of A, it presents a compelling investment opportunity. The company’s strong track record, dividend payouts, and strategic acquisitions make it an attractive choice for investors.

Maximus, Inc. is a leading operator of government health and human services programs globally. It has solid relationships with governments, long-term contracts, and a focus on long-term client partnerships. Recent acquisitions, like Stirling Institute and BZ Bodies, have enhanced its services and capabilities, contributing to its growth.

The Zacks Consensus Estimate for Maximus’ fiscal 2025 earnings is $5.95, reflecting a 2% increase in the past 60 days. The company’s current ratio of 1.49 surpasses the industry average, indicating strong liquidity. Other stocks to consider in the Business Services sector include UiPath (PATH) and RB Global, Inc. (RBA).

RB Global, Inc. (RBA) and UiPath, Inc. (PATH) are other strong contenders in the Business Services sector. RB Global has a Zacks Rank of 1, with a long-term earnings growth expectation of 10.6%. UiPath boasts a Zacks Rank of 1 and a long-term earnings growth expectation of 19.3%. Both companies have delivered impressive earnings surprises in the past.

Investors looking for potential high-growth stocks can explore five handpicked options set to double in 2024. These stocks have the potential for significant gains, with previous recommendations soaring by over 100%. Most of these stocks are flying under the radar, presenting an opportunity for early investment in promising ventures.



Read more at Nasdaq: Here’s Why You Should Add Maximus Stock to Your Portfolio Now